Cardiotoxicity of immune checkpoint inhibitors: A meta-analysis of randomized clinical trials

被引:0
|
作者
Agostinetto, E. [1 ]
Eiger, D. [1 ]
Lambertini, M. [2 ]
Ceppi, M. [3 ]
Bruzzone, M. [3 ]
Ponde, N. F. [4 ]
Plummer, C. [5 ]
Awada, A. H. [6 ]
Piccart, M. [6 ]
de Azambuja, E. [1 ]
机构
[1] Inst Jules Bordet, Acad Trials Promoting Team, Brussels, Belgium
[2] IRCCS Osped Policlin San Martino, Dept Med Oncol, Genoa, Italy
[3] IRCCS Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy
[4] AC Camargo Canc Ctr, Clin Oncol, Sao Paulo, Brazil
[5] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[6] Inst Jules Bordet, Oncol Dept, Brussels, Belgium
关键词
D O I
10.1016/j.annonc.2020.10.528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
41P
引用
收藏
页码:S1432 / S1432
页数:1
相关论文
共 50 条
  • [31] Cardiotoxicity with immune checkpoint inhibitors
    Rajamani, Sridharan
    Zafra, Christina D.
    Turk, Jim
    Lebrec, Herve
    Vargas, Hugo M.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 111
  • [32] Complete response to immune checkpoint inhibitors-based therapy in advanced renal cell carcinoma patients. A meta-analysis of randomized clinical trials
    Iacovelli, R.
    Ciccarese, C.
    Schutz, F. A.
    Tortora, G.
    de Velasco, G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (10) : 798.e17 - 798.e24
  • [33] Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
    Grassadonia, Antonino
    Sperduti, Isabella
    Vici, Patrizia
    Iezzi, Laura
    Brocco, Davide
    Gamucci, Teresa
    Pizzuti, Laura
    Maugeri-Sacca, Marcello
    Marchetti, Paolo
    Cognetti, Gaetana
    De Tursi, Michele
    Natoli, Clara
    Barba, Maddalena
    Tinari, Nicola
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [34] Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized clinical trials
    Dang, Shoutao
    Zhang, Shurong
    Zhao, Jingyang
    Li, Xinyu
    Li, Wei
    CANCER MEDICINE, 2023, 12 (20): : 20277 - 20286
  • [35] Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer
    Berti, Alvise
    Bortolotti, Roberto
    Dipasquale, Mariachiara
    Kinspergher, Stefania
    Prokop, Larry
    Grandi, Guido
    Inchiostro, Sandro
    Paolazzi, Giuseppe
    Caffo, Orazio
    Veccia, Antonello
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 162
  • [36] Immune checkpoint inhibitors (ICI): A meta-analysis of immune-related adverse events (irAE) from cancer clinical trials.
    El Osta, Badi Edmond
    Hu, Fengjiao
    Sadek, Ramses F.
    Chintalapally, Rohini
    Tang, Shou-Ching
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] IMMUNE CHECKPOINT INHIBITORS AND MYOPERICARDIAL DISEASE - A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS VS. OBSERVATIONAL STUDIES
    Alexander, Grace
    Sharma, Akash
    Chu, Jian H.
    Markopoulos, Artemis
    Maloul, Gilgamish
    Ayub, Muhammad Talha
    Okwuosa, Tochi M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2162 - 2162
  • [38] Efficacy and safety of immune checkpoint inhibitors in gastric cancer: a network meta-analysis of well-designed randomized controlled trials
    Pan, Siwei
    Li, Kai
    Huang, Baojun
    Huang, Jinyu
    Xu, Huimian
    Zhu, Zhi
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
  • [39] Methodological and reporting issues for meta-analysis of immune checkpoint inhibitor-associated cardiotoxicity. Letter regarding the article 'Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis'
    Chiang, Cho-Han
    Chiang, Cho-Hsien
    Chiang, Cho-Hung
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (06) : 1142 - 1143
  • [40] Immune Checkpoint Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis
    Nielsen, Dorte Lisbet
    Juhl, Carsten Bogh
    Nielsen, Ole Haagen
    Chen, Inna Markovna
    Herrmann, Joerg
    JAMA ONCOLOGY, 2024,